Variantyx is a technology-driven precision medicine company providing disruptive solutions to the precision oncology, rare genetic disorders, and reproductive health markets. Our OncoAlly(TM) test uses a proprietary whole genome analysis platform that allows us to better identify the unique genetic alterations in a patient’s tumor, leading to improved personalized treatment recommendations.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes